Blueberry CEO presents a keynote address at the recent AMR MRC workshop in London

John Ridden presented a Keynote address at the MRC Workshop in London on the 25th November 2014. The topic of this important meeting ‘Accelerating therapeutic and diagnostic development’. John commented that this meeting brings together a number of influential scientists from both academia and industry to discuss the challenges of how we can treat antimicrobial resistant infections. The MRC have announced a large new grant pool specifically to encourage research in AMR through innovative new treatments, diagnostic tests and novel therapeutic modalities

2018-02-13T12:31:35+00:00 November 26th, 2014|